MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Pro

Is Highmark's Digital Therapeutics Coverage a Game Changer for Investors

2 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Is MedLink Telehealth's Expanded Coverage a Game Changer for Patient Growth

4 months ago

Is Netflix's Strategic Pivot a Game Changer for Investors

4 months ago

Is Riot Platforms' AI Pivot a Game-Changer for Investors

4 months ago

Is Clorox's Digital Transformation a Game Changer for Operational Efficiency

3 months ago

Not Just Tech: Invest in Innovation With Healthcare

Investors seeking AI innovation exposure have traditionally focused on mega-cap tech names due to their direct role in AI development.

XLV

Stock News•1 week ago

Teladoc's Recovery Story Is Starting to Take Shape. Should You Buy the Stock?

Teladoc's business is slowly improving from several initiatives, though potential headwinds remain that could derail progress.

TDOC

Stock News•1 week ago

Top National Health Plan Extends Agreement for Mental Health and Expands Dario Partnership into Cardiometabolic Care, Demonstrating Successful Multi-Condition Growth Strategy

DarioHealth's revenue opportunity under a top-5 U.S. health plan could approximately triple after the plan extended its mental health agreement and added Dario's hypertension solution, reinforcing the...

DRIO

Stock News•2 months ago

Digital Therapeutics Market to Reach US$ 38.2 Billion by 2030 as Software-Based Care Redefines Modern Medicine - Wissen Research

The global digital therapeutics market is projected to grow from $10.5B in 2025 to $38.2B by 2030. This expansion reflects a compound annual growth rate driven by the increasing integration of softwar...